Literature DB >> 18499452

Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogs.

Susan L Mercer1, Christopher W Cunningham, Natalie D Eddington, Andrew Coop.   

Abstract

Numerous studies have shown that many clinically employed opioid analgesics are substrates for P-glycoprotein (P-gp), suggesting that up-regulation of P-gp may contribute to the development of central tolerance to opioids. The studies herein focus on the development of SAR for P-gp substrate activity in the meperidine series of opioids. Addition of a 3-OH to meperidine and the ketone analog of meperidine yielding bemidone and ketobemidone, respectively, significantly increased P-gp substrate affinity. The results of this study have implications in the development of novel analgesics to be utilized as tools to study the contribution of P-gp on the development of central tolerance to opioids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499452      PMCID: PMC2492381          DOI: 10.1016/j.bmcl.2008.04.046

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Compounds related to pethidine-IV. New general chemical methods of increasing the analgesic activity of pethidine.

Authors:  P A JANSSEN; N B EDDY
Journal:  J Med Pharm Chem       Date:  1960-02

3.  Opioids and efflux transporters. Part 1: P-glycoprotein substrate activity of N-substituted analogs of meperidine.

Authors:  Susan L Mercer; Hazem E Hassan; Christopher W Cunningham; Natalie D Eddington; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2006-12-21       Impact factor: 2.823

4.  A rapid, high-yield conversion of codeine to morphine.

Authors:  K C Rice
Journal:  J Med Chem       Date:  1977-01       Impact factor: 7.446

5.  Increased brain P-glycoprotein in morphine tolerant rats.

Authors:  C L Aquilante; S P Letrent; G M Pollack; K L Brouwer
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

6.  Rational use of in vitro P-glycoprotein assays in drug discovery.

Authors:  J W Polli; S A Wring; J E Humphreys; L Huang; J B Morgan; L O Webster; C S Serabjit-Singh
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

Review 7.  P-glycoprotein: from genomics to mechanism.

Authors:  Suresh V Ambudkar; Chava Kimchi-Sarfaty; Zuben E Sauna; Michael M Gottesman
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

8.  Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats.

Authors:  Hazem E Hassan; Alan L Myers; Insong J Lee; Andrew Coop; Natalie D Eddington
Journal:  J Pharm Sci       Date:  2007-09       Impact factor: 3.534

9.  Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs.

Authors:  Christopher W Cunningham; Susan L Mercer; Hazem E Hassan; John R Traynor; Natalie D Eddington; Andrew Coop
Journal:  J Med Chem       Date:  2008-02-27       Impact factor: 7.446

10.  Variable modulation of opioid brain uptake by P-glycoprotein in mice.

Authors:  Claude Dagenais; Candace L Graff; Gary M Pollack
Journal:  Biochem Pharmacol       Date:  2004-01-15       Impact factor: 5.858

View more
  4 in total

Review 1.  Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease.

Authors:  William C Motel; Andrew Coop; Christopher W Cunningham
Journal:  Mini Rev Med Chem       Date:  2013-03       Impact factor: 3.862

Review 2.  Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.

Authors:  Susan L Mercer; Andrew Coop
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 3.  Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Authors:  Christopher W Cunningham; Richard B Rothman; Thomas E Prisinzano
Journal:  Pharmacol Rev       Date:  2011-03-28       Impact factor: 25.468

4.  Opioids and efflux transporters. Part 4: influence of N-substitution on P-glycoprotein substrate activity of noroxymorphone analogues.

Authors:  Matthew D Metcalf; Andrew D Rosicky; Hazem E Hassan; Natalie D Eddington; Andrew Coop; Christopher W Cunningham; Susan L Mercer
Journal:  Bioorg Med Chem Lett       Date:  2014-05-22       Impact factor: 2.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.